Does GOLIMUMAB Cause Off label use? 8,764 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 8,764 reports of Off label use have been filed in association with GOLIMUMAB (SIMPONI ARIA). This represents 12.7% of all adverse event reports for GOLIMUMAB.
8,764
Reports of Off label use with GOLIMUMAB
12.7%
of all GOLIMUMAB reports
1,664
Deaths
3,186
Hospitalizations
How Dangerous Is Off label use From GOLIMUMAB?
Of the 8,764 reports, 1,664 (19.0%) resulted in death, 3,186 (36.4%) required hospitalization, and 2,017 (23.0%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GOLIMUMAB. However, 8,764 reports have been filed with the FAERS database.
What Other Side Effects Does GOLIMUMAB Cause?
Drug ineffective (17,959)
Rheumatoid arthritis (12,272)
Pain (11,443)
Fatigue (9,626)
Alopecia (8,394)
Rash (8,331)
Joint swelling (8,264)
Arthralgia (7,968)
Abdominal discomfort (7,902)
Drug intolerance (7,802)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which GOLIMUMAB Alternatives Have Lower Off label use Risk?
GOLIMUMAB vs GOLODIRSEN
GOLIMUMAB vs GONADORELIN
GOLIMUMAB vs GONADOTROPHIN, CHORIONIC
GOLIMUMAB vs GOSERELIN
GOLIMUMAB vs GRAMICIDIN